Stryker Q2 FY26: where the revenue came from and where it went
The whole income statement of Stryker for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2026
- Reported
- Jul 31, 2026
Revenue$6.59B
+9% year over year
Gross profit$4.50B
68% margin
Operating profit$1.66B
25% margin
Net profit$1.28B
19% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 6.59 | 100% | +9% |
| Med surg & neurotechnology | 3.63 | 55% | |
| Orthopaedics & spine | 2.96 | 45% | |
| Cost of revenue | −2.09 | 32% | |
| Gross profit | 4.50 | 68% margin | +4pp |
| R&D | −0.43 | 6% | +0pp |
| SG&A | −2.23 | 34% | −1pp |
| Other | −0.18 | 3% | +0pp |
| Operating profit | 1.66 | 25% margin | +7pp |
| Interest & other costs | −0.10 | ||
| Tax | −0.29 | ||
| Net profit | 1.28 | 19% margin | +5pp |
209 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest